3Ereth MH, Nuttall GA, Oliver WC Jr, et al. Temperature and duration of cardiopulmonary bypass influence transfusion requirements. Exp Oncol, 2007, 29(1):67-70
5British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines for the use of platelet transfusion [J]. Br J Haematol, 2003, 122(1):10-23
6Shapiro R, Rao AS, Fontes P, et al. Combined kidney/bone marrow transplantation-Evidence of augmentation of chimerism [J]. Transplantation, 1995, 59:306-309
7Hundri-Haspl ZJurakovi-Loncar N,Grgicevi- D, et al. Alloimmunizations following blood transfusions [J]. Acta Med Croatica, 1994, 48 (4-5): 193-197
9Charles A, Schiffer, Kenneth C, et al. Platelet transfusion for patients with cancer[J]. Clinical Oncolcgy, 2001, 19(5): 1519-1538
10Lapierre V, Auperin A,Robinet E,et al. Immune modulation and microchimerism after unmodified versus leukoreduced aUogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion. 2007 Sep; 47(9):1691-1699
